Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Fava

Showing results (31-40 of 798) with videos related to

Pageof 80
Sort By:
The Journal of Clinical Psychiatry|November 14, 2009
Folate in depression: efficacy, safety, differences in formulations, and clinical issuesMaurizio Fava, David Mischoulon
Journal of Psychosomatic Research|October 16, 2002
Depression and public health: an overviewPaolo Cassano, Maurizio Fava
Journal of Psychopharmacology (Oxford, England)|January 13, 2006
Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: a case reportEric Hazen, Maurizio Fava
Nature. Mental Health|January 9, 2025
What should constitute a control condition in psychedelic drug trials?Luana Colloca, Maurizio Fava
The Journal of Clinical Psychiatry|February 6, 2009
Are nutritional supplements ready for prime time?David Mischoulon, Maurizio Fava
Innovations in Clinical Neuroscience|December 2, 2011
Fatigue as a residual symptom of depressionSteven D Targum, Maurizio Fava
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 1, 2008
Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDDGeorge I Papakostas, Maurizio Fava
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 10, 2006
A meta-analysis of clinical trials comparing milnacipran, a serotonin--norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorderGeorge I Papakostas, Maurizio Fava
Dialogues in Clinical Neuroscience|January 28, 2009
Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorderGeorge I Papakostas, Maurizio Fava
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 16, 2006
A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorderGeorge I Papakostas, Maurizio Fava
Pageof 80

Showing results (31-40 of 798) with videos related to

Sort By:
Pageof 80
The Journal of Clinical Psychiatry|November 14, 2009
Folate in depression: efficacy, safety, differences in formulations, and clinical issuesMaurizio Fava, David Mischoulon
Journal of Psychosomatic Research|October 16, 2002
Depression and public health: an overviewPaolo Cassano, Maurizio Fava
Journal of Psychopharmacology (Oxford, England)|January 13, 2006
Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: a case reportEric Hazen, Maurizio Fava
Nature. Mental Health|January 9, 2025
What should constitute a control condition in psychedelic drug trials?Luana Colloca, Maurizio Fava
The Journal of Clinical Psychiatry|February 6, 2009
Are nutritional supplements ready for prime time?David Mischoulon, Maurizio Fava
Innovations in Clinical Neuroscience|December 2, 2011
Fatigue as a residual symptom of depressionSteven D Targum, Maurizio Fava
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 1, 2008
Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDDGeorge I Papakostas, Maurizio Fava
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 10, 2006
A meta-analysis of clinical trials comparing milnacipran, a serotonin--norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorderGeorge I Papakostas, Maurizio Fava
Dialogues in Clinical Neuroscience|January 28, 2009
Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorderGeorge I Papakostas, Maurizio Fava
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 16, 2006
A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorderGeorge I Papakostas, Maurizio Fava
Pageof 80